Showing 1 - 4 results of 4 for search 'Sergio Fragoso-Saavedra', query time: 0.03s Refine Results
  1. 1
    Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study

    Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study by Isaac Núñez, Isaac Núñez, Joshua Gillard, Joshua Gillard, Joshua Gillard, Joshua Gillard, Sergio Fragoso-Saavedra, Sergio Fragoso-Saavedra, Sergio Fragoso-Saavedra, Dorien Feyaerts, León Islas-Weinstein, Angel A. Gallegos-Guzmán, Uriel Valente-García, Justin Meyerowitz, J. Daniel Kelly, J. Daniel Kelly, J. Daniel Kelly, Han Chen, Edward Ganio, Alexander Benkendorff, Jaime Flores-Gouyonnet, Pedro Dammann-Beltrán, José Francisco Heredia-González, Gabriela A. Rangel-Gutiérrez, Catherine A. Blish, Catherine A. Blish, Catherine A. Blish, Catherine A. Blish, Kari C. Nadeau, Kari C. Nadeau, Kari C. Nadeau, Kari C. Nadeau, Garry Nolan, Jose C. Crispín, Jose C. Crispín, David R. McIlwain, Brice Gaudillière, Sergio I. Valdés-Ferrer, Sergio I. Valdés-Ferrer

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational studyResearch in context

    Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational studyResearch in context by Isaac Núñez, Miguel García-Grimshaw, Santa E. Ceballos-Liceaga, Carla Toledo-Salinas, Guillermo Carbajal-Sandoval, Luisa Sosa-Laso, Gabriel García-Rodríguez, Ricardo Cortés-Alcalá, Alethse de la Torre, Sergio Fragoso-Saavedra, Alejandro Quintero-Villegas, Hugo López-Gatell, Gustavo Reyes-Terán, Sergio Iván Valdés-Ferrer

    Published 2023-01-01
    Get full text
    Article
  3. 3
    A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol

    A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortal... by Sergio Fragoso-Saavedra, David A. Iruegas-Nunez, Alejandro Quintero-Villegas, H. Benjamín García-González, Isaac Nuñez, Sergio L. Carbajal-Morelos, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Yanink Caro-Vega, Juan José Calva, Verónica Luqueño-Martínez, Alejandra González-Duarte, Brenda Crabtree-Ramírez, José C. Crispín, Juan Sierra-Madero, Pablo F. Belaunzarán-Zamudio, Sergio I. Valdés-Ferrer

    Published 2020-10-01
    Get full text
    Article
  4. 4
    Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial

    Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial by Sergio Fragoso-Saavedra, Isaac Núñez, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Daniel Manzur-Sandoval, Alejandro Quintero-Villegas, H. Benjamín García-González, Sergio L. Carbajal-Morelos, Sergio PoncedeLeón-Rosales, José Gotés-Palazuelos, José A. Maza-Larrea, J. Javier Rosales-de la Rosa, Dafne Diaz-Rivera, Edgar Luna-García, Elvira Piten-Isidro, Perla M. Del Río-Estrada, Mario Fragoso-Saavedra, Yanink Caro-Vega, Isabella Batina, León Islas-Weinstein, David A. Iruegas-Nunez, Juan J. Calva, Pablo F. Belaunzarán-Zamudio, Juan Sierra-Madero, José C. Crispín, Sergio Iván Valdés-Ferrer

    Published 2022-11-01
    Get full text
    Article

Search Tools: